HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced today it has been sel...
HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, is pleased to announce that W...
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution network in support of commercial goals for Aurix Foundational Aurix product is well positioned wi...
HOUSTON, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (“Nuo” or the “Company”) announced that it is aware of an unsolicited “mini-tender” offer by Alternative Liquidity Index, LP to purchase up to 1,820,000 shares of Nuo common stock, ap...
Nuo Therapeutics Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid Services Nuo Therapeutics Announces Publication of Final Decision Memo for Autologous Blood Derived Products ...
Nuo Therapeutics Announces Recapitalization and Exchange Agreement that Simplifies Capital Structure PR Newswire HOUSTON, Oct. 6, 2020 HOUSTON , Oct. 6, 2020 /PRNewswire/ -- Nuo Therapeutics, Inc. (OTC Pink: AURX) ("Nuo" or the "Company"), today announced...
GAITHERSBURG, Md. , March 22, 2019 /PRNewswire/ -- Nuo Therapeutics, Inc. (OTCQB: AURX) ("Nuo" or the "Company"), today provided an update on ongoing interactions with Centers for Medicare & Medicaid Services' (CMS) Coverage and Analysis Group (CAG) representatives. ...
News, Short Squeeze, Breakout and More Instantly...
AUDEO ONCOLOGY INC. Company Name:
AURX Stock Symbol:
OTCMKTS Market:
HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced today it has been sel...
HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, is pleased to announce that W...
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution network in support of commercial goals for Aurix Foundational Aurix product is well positioned wi...